These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 34870)
21. [Determination of the concentrations of niflumic acid in the plasma and synovial tissue following repeated administration of capsules]. Dorfmann H; Gendron A; Duchenne P Rev Rhum Mal Osteoartic; 1987 Apr; 54(4):339-41. PubMed ID: 3602910 [TBL] [Abstract][Full Text] [Related]
22. [An anti-inflammatory association in oral surgery. A report on 90 cases]. Collas P Chir Dent Fr; 1977 May; 47(352):59-64. PubMed ID: 354904 [No Abstract] [Full Text] [Related]
23. Flufenamic acid in rheumatoid arthritis. The second six months of treatment. Simpson MR; Simpson NR; Masheter HC; Hardy SM Ann Phys Med; 1966; Suppl():110-3. PubMed ID: 6004859 [No Abstract] [Full Text] [Related]
28. The pharmacokinetics and availability of niflumic acid in humans. Houin G; Tremblay D; Bree F; Dufour A; Ledudal P; Tillement JP Int J Clin Pharmacol Ther Toxicol; 1983 Mar; 21(3):130-4. PubMed ID: 6852999 [TBL] [Abstract][Full Text] [Related]
29. Detection of the non-steroidal anti-inflammatory drug niflumic acid in humans: a combined 19F-MRS in vivo and in vitro study. Bilecen D; Schulte AC; Kaspar A; Küstermann E; Seelig J; Elverfeldt D; Scheffler K NMR Biomed; 2003 May; 16(3):144-51. PubMed ID: 12884358 [TBL] [Abstract][Full Text] [Related]
30. New drugs. 8. Flufenamic acid in rheumatoid arthritis. Comparison with aspirin and the results of extended treatment. Simpson MR; Simpson NR; Masheter HC Ann Phys Med; 1966 May; 8(6):208-13. PubMed ID: 5937788 [No Abstract] [Full Text] [Related]
31. [Clinical evaluation in rheumatology of a non-steroid anti-inflammatory agent, niflumic acid, as compared with other anti-inflammatory drugs]. Menarini C; Ferri S; Lanzarini AM; Alianti M Reumatismo; 1971; 23(6):318-39. PubMed ID: 5293571 [No Abstract] [Full Text] [Related]
32. Discussion on clinical trials of the fenamates. Ann Phys Med; 1966; Suppl():129-34. PubMed ID: 5306340 [No Abstract] [Full Text] [Related]
33. Experimental observations on flufenamic, mefenamic, and meclofenamic acids. IV. Toleration by normal human subjects. Holmes EL Ann Phys Med; 1966; Suppl():36-49. PubMed ID: 4895006 [No Abstract] [Full Text] [Related]
34. [Flufenamic acid]. Südhof H Dtsch Med Wochenschr; 1968 Dec; 93(50):2455. PubMed ID: 5698984 [No Abstract] [Full Text] [Related]
35. [Analytical reactions of mefenamic and flufenamic acids]. Devaux G; Mesnard P; Brisson AM Ann Pharm Fr; 1969 Mar; 27(3):239-48. PubMed ID: 5400246 [No Abstract] [Full Text] [Related]
36. The breast milk excretion on flufenamic acid. Buchanan RA; Eaton CJ; Koeff ST; Kinkel AW Curr Ther Res Clin Exp; 1969 Aug; 11(8):533-8. PubMed ID: 4979706 [No Abstract] [Full Text] [Related]
38. [Flufenamic acid in rheumatology]. Cabanel G; Phélip X; Verdier JM J Med Lyon; 1970 Oct; 51(195):1771-2 passim. PubMed ID: 5317350 [No Abstract] [Full Text] [Related]
39. [Clinical study of a new anthranilic acid derivative: flufenamic acid]. Colombo B; Chériè Lignière G; Mantellini P Reumatismo; 1969; 21(3):114-21. PubMed ID: 4929605 [No Abstract] [Full Text] [Related]
40. [Pharmacological properties of a series of derivatives of mefenamic and flufenamic acids]. Linari G; Spanò R Farmaco Sci; 1971 Apr; 26(4):303-11. PubMed ID: 5559990 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]